RSS Feeds
Search

Press releases

Press releases

Displaying 1..1 of 1 - per page
Order by
ACTIVE BIOTECH AND CHELSEA THERAPEUTICS TO CO-DEVELOP PORTFOLIO OF THERAPEUTICS TARGETING AUTOIMMUNE DISEASE AND TRANSPLANT REJECTION
Agreement Creates Synergistic Alliance Focused on Immune-Mediated Inflammatory Disorders More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Sep 2011 - 95 pages - $3,500
Autoimmune Market Access in India – Market opportunities for cost-effective biosimilars
Aug 2011 - 58 pages - $5,700
Immunomodulators
Aug 2007 - 345 pages - $2,875
Autoimmune Treatment (2009 - 2014)
Sep 2009 - 159 pages - $4,650
Autoimmune Market Access in China – New biologic therapies drive future growth
Sep 2011 - 87 pages - $5,700
Autoimmune Diseases Therapy Area Pipeline Report
Nov 2010 - 399 pages - $1,495
Gastrointestinal Disorders Therapy Area Pipeline Report
Nov 2010 - 933 pages - $1,495
Psychotic disorders Therapy Area Pipeline Report
Nov 2010 - 308 pages - $1,495
Haemophilia and Blood Coagulation Disorders Therapy Area Pipeline Report
Nov 2010 - 330 pages - $1,495
Immune Network, Ltd. - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Therapeutic target
Immune related disorders del
Autoimmune disease (non-specific) del

Browse By

Industry sector
Assay systems
Diagnostic test systems
Gene therapy
Human diagnostics
Human therapeutics
Manufacturing
Nanotechnology
Other
Research supplies
Stem cells
Year
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us